Search - Prime Therapeutics
Navigate to
-
Insights from Academy of Managed Care Pharmacy (AMCP) Nexus 2023
PA Sub-Categories: Specialty drugs Prime Article: Stories -
Jessica Johnson, clinical consultant at Prime Therapeutics, shares some ways to avoid common fraud schemes
Prime Article: Perspectives -
Perspectives High-Cost Therapy Profile: June 2024 Detailed information about Imetelstat Intravenous (IV) June 14, 2024 Oncology Imetelstat Intravenous (IV) Geron Proposed indications For the...
-
publications High-Cost Therapy Profile: February 2025 Revakinagene taroretcel Ocular implant | Neurotech Pharmaceuticals, Inc. Ophthalmology February 13, 2025 Proposed indications Macular...
-
publications 2024 Employer Market Insights Report June 28, 2024 Prime is pleased to present the seventh edition of the Employer Market Insights Report. Within this one-of-a-kind publication,...
-
Cover image for FDA Decisions Expected_February 2025 Drug pipeline for February 2025 Prime Therapeutics /fda-decisions-expected-february-2025 About Prime Therapeutics Prime Therapeutics logo Prime...
Prime Article: Research & Publications PA Research & Publications: FDA Decisions Expected -
Publications High Cost Therapy Profile: October 2024 Eladocagene Exuparvovec October 15, 2024 Neurology Eladocagene Exuparvovec Intrapuraminal PTC Therapeutics, Inc. Proposed indications...
-
Event features Pat Gleason, AVP, health outcomes at Prime Therapeutics
Prime Article: Events -
Cover image for FDA Decisions Expected: November 2024 Drug pipeline for November 2024 Prime Therapeutics /fda-decisions-expected-november-2024 Prime Therapeutics’ FDA Decisions Expected outlines...
Prime Article: Research & Publications PA Research & Publications: FDA Decisions Expected -
Tap into predictive analytics Our advanced analytics platform helps boost your clinical impact and drive down costs by delivering descriptive, diagnostic, predictive and prescriptive analytics....
-
Get support from the specialists in specialty We provide end-to-end support for patients taking specialty meds, helping them navigate the care journey. Breadcrumb Home Pharmacy Specialty Pharmacy...
-
Eyebrow High-Cost Therapy Profile: August 2024 Detailed information about intravenous (IV) linvoseltamab August 15, 2024 Oncology Linvoseltamab, intravenous (IV) Regeneron Pharmaceuticals ...
-
See our award-winning people & work Prime delivers unmatched care, groundbreaking research and industry-leading programs and services for health plans, employers and members. Breadcrumb Home Who we...
-
These new solutions reflect Prime's distinctive conflict-free approach to the prescription drug supply chain model.
PA Sub-Categories: Specialty drugs Prime Article: Press Releases -
Comprehensive PDL services With 40+ years of Medicaid pharmacy experience supporting over half the nation’s programs, we help states manage high drug costs and ensure members get the meds they...
-
Upgrade provides streamlined patient support and enhanced digital engagement for data-driven, holistic care
PA Sub-Categories: Specialty drugs Products Prime Article: Press Releases -
-
Prime Careers Spotlight: November 2024 Check out our latest job openings. Together, we can help make health care better by helping clients and members navigate pharmacy benefits. Investment...
-
Cover image for Prime Therapeutics prioritizes patient-centered care, stays ahead of oncology trends Prime simplifies the cancer care pathway through innovative solutions that help manage complex...
PA Sub-Categories: Specialty drugs Products Prime Article: Stories -
PUBLICATIONS FDA Decisions Expected: April 2025 Your monthly synopsis of new drugs expected to hit the market March 14, 2025 Drug pipeline for April 2025 At Prime Therapeutics (Prime), we have...